Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy
Viruses · 2025
DOI: 10.3390/v17070961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Jenna M Hasson und 9 weiteren Autor:innen. Beteiligte Einrichtung: HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA. Hauptthemen laut MEDLINE: Proviruses, HIV-1, HIV Infections, Anti-Retroviral Agents. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S.-South Africa Program for Collaborative Biomedical Research; the National Cancer Institute, NIAID NIH HHS, National Institutes of Allergy and Infectious Diseases (Comprehensive International Program for Research on AIDS [CIPRA]-South Africa.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
HIV-1 proviral landscapes were investigated using near-full-length HIV single-genome sequencing on blood samples from five children with vertically acquired infection and on ART for ~7–9 years. Proviral structures were compared to published datasets in children prior to ART, children on short-term ART, and adults on ART. We found a strong selection for large internal proviral deletions in children, especially deletions of the env gene. Only 2.5% of the proviruses were sequence-intact, lower than in the comparative datasets from adults. Of the proviruses that retained the env gene, >80% contained two or more defects, most commonly stop codons and/or gag start mutations. Significantly fewer defects in the major splice donor site (MSD) and packaging signal were found in the children on short or long-term ART compared to the adults, and tat was more frequently defective in children. These results suggest that different selection pressures may shape the proviral landscape in children compared to adults and reveal potentially different genetic regions to target for measuring the intact HIV reservoir and for achieving HIV remission in children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
- Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA.
- Division of Medical Virology, Department of Pathology, Stellenbosch University, Cape Town 7500, South Africa.
ORCID-Profile: Adam A Capoferri, Michael J Bale, Brian T Luke, Mark F Cotton, Gert van Zyl, Sean C Patro, Mary F Kearney
Förderung
- U.S.-South Africa Program for Collaborative Biomedical Research; the National Cancer Institute
- NIAID NIH HHS
- National Institutes of Allergy and Infectious Diseases (Comprehensive International Program for Research on AIDS [CIPRA]-South Africa
- Intramural National Cancer Institute
- NCI NIH HHS
- Intramural Research Program of the NIH
- intramural NCI funding
- National Institutes of Allergy and Infectious Diseases
Zitieren
APA
Hasson, J. M., Katusiime, M. G., Capoferri, A. A., Bale, M. J., Luke, B. T., Shao, W., Cotton, M. F., van Zyl, G., Patro, S. C., & Kearney, M. F. (2025). Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy. Viruses. https://doi.org/10.3390/v17070961
Vancouver
Hasson JM, Katusiime MG, Capoferri AA, Bale MJ, Luke BT, Shao W, et al. Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy. Viruses. 2025. doi:10.3390/v17070961
BibTeX
@article{Hasson2025,
author = {Hasson, Jenna M and Katusiime, Mary Grace and Capoferri, Adam A and Bale, Michael J and Luke, Brian T and Shao, Wei and Cotton, Mark F and van Zyl, Gert and Patro, Sean C and Kearney, Mary F},
title = {Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17070961}
}
EUVIMED